| Dr Baseer M Qazi, MD | |
|
2501 Compass Rd, Suite 130, Glenview, IL 60026-8000 | |
| (847) 677-1170 | |
| (847) 677-1233 |
| Full Name | Dr Baseer M Qazi |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 22 Years |
| Location | 2501 Compass Rd, Glenview, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386654093 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 036113962 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Advocate Lutheran General Hospital | Park ridge, IL | Hospital |
| Javon Bea Hospital | Rockford, IL | Hospital |
| Mercy Harvard Hospital | Harvard, IL | Hospital |
| Mercy Health System Corp | Janesville, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rockford Health Physicians | 2567374036 | 289 |
| Illinois Gastroenterology Group Llc | 5193857423 | 119 |
| Mercy Health System Corporation | 7416860440 | 459 |
News Archive
SunLink Health Systems, Inc. today announced a loss from continuing operations for its first fiscal quarter ended September 30, 2011 of $305,000, or a loss of $0.04 per fully diluted share, compared to a loss from continuing operations of $2,263,000, or a loss of $0.28 per fully diluted share for the quarter ended September 30, 2010.
This year's IPF World Week (September 21-29) sees healthcare professionals, patient advocacy groups, people living with idiopathic pulmonary fibrosis (IPF), who have an estimated median survival time of two to five years, and their families calling for an integrated approach to further strengthen the national and international network of people working to support patients with this fatal orphan lung disease.
Cempra Pharmaceuticals today announced results from its Phase II clinical trial investigating the efficacy, safety and tolerability of oral administration of our fourth generation macrolide, solithromycin (CEM-101), a fluoroketolide antibiotic, in comparison with oral levofloxacin for the treatment of community-acquired bacterial pneumonia (CABP).
In a rare show of bipartisanship for the mostly polarized 115th Congress, Republican and Democratic Senate leaders announced a two-year budget deal that would increase federal spending for defense as well as key domestic priorities, including many health programs.
› Verified 7 days ago
| Entity Name | Rockford Health Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043242886 PECOS PAC ID: 2567374036 Enrollment ID: O20031103000584 |
News Archive
SunLink Health Systems, Inc. today announced a loss from continuing operations for its first fiscal quarter ended September 30, 2011 of $305,000, or a loss of $0.04 per fully diluted share, compared to a loss from continuing operations of $2,263,000, or a loss of $0.28 per fully diluted share for the quarter ended September 30, 2010.
This year's IPF World Week (September 21-29) sees healthcare professionals, patient advocacy groups, people living with idiopathic pulmonary fibrosis (IPF), who have an estimated median survival time of two to five years, and their families calling for an integrated approach to further strengthen the national and international network of people working to support patients with this fatal orphan lung disease.
Cempra Pharmaceuticals today announced results from its Phase II clinical trial investigating the efficacy, safety and tolerability of oral administration of our fourth generation macrolide, solithromycin (CEM-101), a fluoroketolide antibiotic, in comparison with oral levofloxacin for the treatment of community-acquired bacterial pneumonia (CABP).
In a rare show of bipartisanship for the mostly polarized 115th Congress, Republican and Democratic Senate leaders announced a two-year budget deal that would increase federal spending for defense as well as key domestic priorities, including many health programs.
› Verified 7 days ago
| Entity Name | Mercy Health System Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598718603 PECOS PAC ID: 7416860440 Enrollment ID: O20031111000307 |
News Archive
SunLink Health Systems, Inc. today announced a loss from continuing operations for its first fiscal quarter ended September 30, 2011 of $305,000, or a loss of $0.04 per fully diluted share, compared to a loss from continuing operations of $2,263,000, or a loss of $0.28 per fully diluted share for the quarter ended September 30, 2010.
This year's IPF World Week (September 21-29) sees healthcare professionals, patient advocacy groups, people living with idiopathic pulmonary fibrosis (IPF), who have an estimated median survival time of two to five years, and their families calling for an integrated approach to further strengthen the national and international network of people working to support patients with this fatal orphan lung disease.
Cempra Pharmaceuticals today announced results from its Phase II clinical trial investigating the efficacy, safety and tolerability of oral administration of our fourth generation macrolide, solithromycin (CEM-101), a fluoroketolide antibiotic, in comparison with oral levofloxacin for the treatment of community-acquired bacterial pneumonia (CABP).
In a rare show of bipartisanship for the mostly polarized 115th Congress, Republican and Democratic Senate leaders announced a two-year budget deal that would increase federal spending for defense as well as key domestic priorities, including many health programs.
› Verified 7 days ago
| Entity Name | Illinois Gastroenterology Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316277817 PECOS PAC ID: 5193857423 Enrollment ID: O20100721000790 |
News Archive
SunLink Health Systems, Inc. today announced a loss from continuing operations for its first fiscal quarter ended September 30, 2011 of $305,000, or a loss of $0.04 per fully diluted share, compared to a loss from continuing operations of $2,263,000, or a loss of $0.28 per fully diluted share for the quarter ended September 30, 2010.
This year's IPF World Week (September 21-29) sees healthcare professionals, patient advocacy groups, people living with idiopathic pulmonary fibrosis (IPF), who have an estimated median survival time of two to five years, and their families calling for an integrated approach to further strengthen the national and international network of people working to support patients with this fatal orphan lung disease.
Cempra Pharmaceuticals today announced results from its Phase II clinical trial investigating the efficacy, safety and tolerability of oral administration of our fourth generation macrolide, solithromycin (CEM-101), a fluoroketolide antibiotic, in comparison with oral levofloxacin for the treatment of community-acquired bacterial pneumonia (CABP).
In a rare show of bipartisanship for the mostly polarized 115th Congress, Republican and Democratic Senate leaders announced a two-year budget deal that would increase federal spending for defense as well as key domestic priorities, including many health programs.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Baseer M Qazi, MD 2501 Compass Rd, Suite 130, Glenview, IL 60026-8000 Ph: (847) 677-1170 | Dr Baseer M Qazi, MD 2501 Compass Rd, Suite 130, Glenview, IL 60026-8000 Ph: (847) 677-1170 |
News Archive
SunLink Health Systems, Inc. today announced a loss from continuing operations for its first fiscal quarter ended September 30, 2011 of $305,000, or a loss of $0.04 per fully diluted share, compared to a loss from continuing operations of $2,263,000, or a loss of $0.28 per fully diluted share for the quarter ended September 30, 2010.
This year's IPF World Week (September 21-29) sees healthcare professionals, patient advocacy groups, people living with idiopathic pulmonary fibrosis (IPF), who have an estimated median survival time of two to five years, and their families calling for an integrated approach to further strengthen the national and international network of people working to support patients with this fatal orphan lung disease.
Cempra Pharmaceuticals today announced results from its Phase II clinical trial investigating the efficacy, safety and tolerability of oral administration of our fourth generation macrolide, solithromycin (CEM-101), a fluoroketolide antibiotic, in comparison with oral levofloxacin for the treatment of community-acquired bacterial pneumonia (CABP).
In a rare show of bipartisanship for the mostly polarized 115th Congress, Republican and Democratic Senate leaders announced a two-year budget deal that would increase federal spending for defense as well as key domestic priorities, including many health programs.
› Verified 7 days ago
Karen Chiu, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2100 Pfingsten Rd Ste 3001a, Glenview, IL 60026 Phone: 847-657-5840 Fax: 847-657-5732 | |
Lynn K. Martin, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 2550 Waukegan Rd, Suite 100, Glenview, IL 60025 Phone: 847-729-2541 Fax: 847-729-2546 | |
Dr. Jamee Castillo Tantoco, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2050 Pfingsten Rd Ste 320, Glenview, IL 60026 Phone: 847-998-4170 Fax: 847-998-4165 | |
Dr. Gregory Aaron Wallman, DO Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2501 Compass Rd, Suite 100, Glenview, IL 60026 Phone: 847-901-5200 Fax: 847-904-4907 | |
Rebecca Wanting Tsang, M.D., M.P.H. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2150 Pfingsten Rd Ste 3000, Glenview, IL 60026 Phone: 847-657-1900 | |
Dr. Monica S. Borkar, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2100 Pfingsten Rd, Suite B230, Glenview, IL 60026 Phone: 847-657-1900 Fax: 847-657-1961 | |
Joel R. Green, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2100 Pfingsten Rd Ste 3001a, Glenview, IL 60026 Phone: 847-657-5840 Fax: 847-657-5835 |